VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2019

Oct 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2019-10-22

Reporting Person: ALTSHULER DAVID (EVP, Global Research and CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-22	Common Stock	M	3669	$155.57	Acquired	35222	Direct
2019-10-22	Common Stock	S	3669	$194.37	Disposed	31553	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-22	Stock Option (Right to Buy)	$155.57	M	3669	Disposed	2028-02-05	Common Stock (3669)	Direct

Footnotes

F1: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.

F2: The option vests in 16 quarterly installments from 02/06/2018.